Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis
Authors:
- Yasuyuki FujitaYFYasuyuki Fujita
- Hirokatsu MaeHMHirokatsu Mae
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 65 (1) , 65-68
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Granulysin as a Marker for Early Diagnosis of the Stevens–Johnson SyndromeAnnals of Internal Medicine, 2009
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysisNature Medicine, 2008
- Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachmentJournal of Allergy and Clinical Immunology, 2008
- Serum granulysin level as a novel prognostic marker in patients with gastric carcinomaJournal of Gastroenterology and Hepatology, 2007
- Toxic epidermal necrolysisJournal of the American Academy of Dermatology, 2007
- Granulysin in human serum as a marker of cell‐mediated immunityEuropean Journal of Immunology, 2003
- Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas LigandThe American Journal of Pathology, 2003
- A Distinct Pathway of Cell-Mediated Apoptosis Initiated by GranulysinThe Journal of Immunology, 2001
- SCORTEN: A Severity-of-Illness Score for Toxic Epidermal NecrolysisJournal of Investigative Dermatology, 2000
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995